Apolline Blazer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Apolline Blazer has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Béatrice Fervers
Centre Léon Bérard, 69008 Lyon, France
2 shared publications - Guillaume Broc
Univ Paul Valéry Montpellier 3
2 shared publications - Jean-Baptiste Fassier
Unité Mixte de Recherche Epidémiologique et de Surveillance Transport Travail Environnement (UMRESTTE), Hospices Civils de Lyon, Université Claude Bernard Lyon 18, Avenue Rockefeller, 69673, Lyon Cedex 08, France
2 shared publications - Julien Carretier
Département Cancer Environnement, Centre Léon-Bérard, Lyon, France
2 shared publications - Julien Péron
Université Claude Bernard Lyon 1, F-69003 Lyon, France
2 shared publications - Laure Milliat-Guittard
INSERM U1290, University Claude Bernard Lyon 1, Research on Healthcare Performance (RESHAPE), 8 Avenue Rockefeller, Lyon, 69008, France, 33 0770979715
2 shared publications
Latest Publications
- Open Access
- 30 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e86608
REalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)
Background: Women with breast cancer face many barriers to returning to work (RTW) after their treatment. The Facilitating and Sustaining the Return to Work After Breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. Objective: The main objective of the RECOVA-FASTRACS (Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors) study is to evaluate the processes using a realist approach that analyzes what works, how, for whom, and under what circumstances. Methods: The RECOVA-FASTRACS study uses a mixed methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include 2 main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experiences of women who participated in the intervention and key individuals involved in their RTW process. We will use semistructured interviews according to the multiple-case study method. Additionally, to explore organizational and professional practices, focus groups will be conducted with professionals who deliver the intervention. To analyze the trajectories, embedded and iterative integration will combine the qualitative findings with relevant quantitative data from the FASTRACS randomized controlled trial for 5 domains: personal situation, professional situation, RTW, care pathway, intervention tool use, and perceived usefulness. Results: The RECOVA-FASTRACS study received funding in 2022. Recruitment and qualitative data collection began in month 6. Final analyses are expected to be completed by the end of 2026, with dissemination of the main findings anticipated in late 2027. Conclusions: Our mixed methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study.
- 30 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e86608
Open AccessREalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)
Background: Women with breast cancer face many barriers to returning to work (RTW) after their treatment. The Facilitating and Sustaining the Return to Work After Breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. Objective: The main objective of the RECOVA-FASTRACS (Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors) study is to evaluate the processes using a realist approach that analyzes what works, how, for whom, and under what circumstances. Methods: The RECOVA-FASTRACS study uses a mixed methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include 2 main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experiences of women who participated in the intervention and key individuals involved in their RTW process. We will use semistructured interviews according to the multiple-case study method. Additionally, to explore organizational and professional practices, focus groups will be conducted with professionals who deliver the intervention. To analyze the trajectories, embedded and iterative integration will combine the qualitative findings with relevant quantitative data from the FASTRACS randomized controlled trial for 5 domains: personal situation, professional situation, RTW, care pathway, intervention tool use, and perceived usefulness. Results: The RECOVA-FASTRACS study received funding in 2022. Recruitment and qualitative data collection began in month 6. Final analyses are expected to be completed by the end of 2026, with dissemination of the main findings anticipated in late 2027. Conclusions: Our mixed methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study.
- Open Access
- 30 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
REalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)
BACKGROUND Women with breast cancer face many barriers to return to work (RTW) after their treatment. The FAcilitating and SusTain the Return to work After breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. OBJECTIVE The main objective of the RECOVA-FASTRACS study is to evaluate the processes of the using a realist approach that analyses what works, how, for whom and under what circumstances. METHODS The RECOVA-FASTRACS study uses a mixed-methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include two main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experience of women who participated in the intervention and key individuals involved in their RTW process. We will use semi-structured interviews according to the multiple-case study method. Additionally, to explore organisational and professional practices, focus groups will be conducted with professionals who deliver the intervention. RESULTS To analyse the trajectories, embedded and iterative integration will combine the qualitative findings, with relevant quantitative data from the FASTRACS randomised controlled trial for five domains (i.e. personal situation, professional situation, return to work, care pathway, intervention tool use and perceived usefulness). CONCLUSIONS Our mixed-methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study. CLINICALTRIAL
- 30 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessREalist COllaborative eVAluation of a work disability prevention programme for breast cancer survivors: Protocol of the RECOVA-FASTRACS realist evaluation (Preprint)
BACKGROUND Women with breast cancer face many barriers to return to work (RTW) after their treatment. The FAcilitating and SusTain the Return to work After breast Cancer (FASTRACS) intervention aims to facilitate and sustain functional RTW. OBJECTIVE The main objective of the RECOVA-FASTRACS study is to evaluate the processes of the using a realist approach that analyses what works, how, for whom and under what circumstances. METHODS The RECOVA-FASTRACS study uses a mixed-methods design to assess the implementation, context, and impact mechanisms of the FASTRACS intervention. The qualitative analysis will include two main components: a trajectory analysis and a focus group assessment. The trajectory analysis will examine the experience of women who participated in the intervention and key individuals involved in their RTW process. We will use semi-structured interviews according to the multiple-case study method. Additionally, to explore organisational and professional practices, focus groups will be conducted with professionals who deliver the intervention. RESULTS To analyse the trajectories, embedded and iterative integration will combine the qualitative findings, with relevant quantitative data from the FASTRACS randomised controlled trial for five domains (i.e. personal situation, professional situation, return to work, care pathway, intervention tool use and perceived usefulness). CONCLUSIONS Our mixed-methods realist evaluation will provide a detailed analysis of the intervention processes, helping to identify impact mechanisms within specific contexts. This approach is meant to ensure a more informed and realist deployment of the intervention by professionals following the study. CLINICALTRIAL